These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1144821)

  • 21. [The frequency of cardiovascular symptoms in the male population aged 40-59 from the first pair of the Warsaw factories covered by the Polish trial on multifactorial prevention of I.H.D.(author's transl)].
    Rywik S; Charzewska J; Napierala M; Szostak WB; Wagrowska H; Bieganowska K; Michalski E
    Przegl Lek; 1977; 34(8):621-5. PubMed ID: 928808
    [No Abstract]   [Full Text] [Related]  

  • 22. [The general discription of the population of the first pair of the Warsaw factories covered by the Polish trial on multifactorial prevention of I.H.D. (author's transl)].
    Rywik S; Charzewska J; Napierala M; Bieganowska K; Wagrowska H; Szostak WB; Michalski E
    Przegl Lek; 1977; 34(8):615-20. PubMed ID: 928807
    [No Abstract]   [Full Text] [Related]  

  • 23. [The occurence of some risk factors of coronary disease in a group of men with hypertriglyceridemia (author's transl)].
    Sznajd J; Magdoń M; Wasowicz B; Woroniecka-Wrześniewska M; Kawecka-Jaszcz K; Zarnecki A
    Przegl Lek; 1977; 34(8):647-53. PubMed ID: 928813
    [No Abstract]   [Full Text] [Related]  

  • 24. [To the dependences between glucose tolerance and serum lipid concentration (author's transl)].
    Knubbmann R; Toeller M
    Offentl Gesundheitswes; 1973 Sep; 35(9):497-500. PubMed ID: 4271388
    [No Abstract]   [Full Text] [Related]  

  • 25. [The prevalence and mutual correlations between the predisposing factors of ischemic heart disease in urban population of males under 47 years of age (author's transl)].
    Simon J; Voleníková L; Svojgrová M
    Cas Lek Cesk; 1974 Feb; 113(9):258-62. PubMed ID: 4434448
    [No Abstract]   [Full Text] [Related]  

  • 26. [The prevalence of hypercholesterolemia in the male population covered by Polish trial on prevention of ischaemic heart disease (author's transl)].
    Chotkowska E; Rywik S; Szostak WB; Charzewska J; Sznajd J; Wasowicz B; Magdoń M; Nowacki G
    Przegl Lek; 1979; 36(10):737-41. PubMed ID: 515458
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hyperlipoproteidemia and other factors increasing coronary heart disease risk (author's transl)].
    Magdoń M
    Przegl Lek; 1975; 32(6):538-46. PubMed ID: 1144823
    [No Abstract]   [Full Text] [Related]  

  • 28. [Serum lactic acid levels during physical training in normal subjects and in patients with coronary heart disease (author's transl)].
    Román O; Gutiérrez M; Camuzzi AL; Villalón E; Donoso O; Klenner C
    Rev Med Chil; 1980 Apr; 108(4):304-11. PubMed ID: 7433791
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serum high density lipoprotein cholesterol (HDL-C) level and its regulating factors in healthy subjects and patients with coronary heart disease (author's transl)].
    Li ZX
    Zhonghua Yi Xue Za Zhi; 1982 Jan; 62(1):13-7. PubMed ID: 6805908
    [No Abstract]   [Full Text] [Related]  

  • 30. [Smoking and other factors of cornary heart disease risk (author's transl)].
    Sznajd J; Magdoń M; Pach J; Celiński A; Koblink TL
    Przegl Lek; 1975; 32(6):550-5. PubMed ID: 1144825
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucose intolerance and coronary heart disease incidence--recent observations.
    Epstein FH
    Horm Metab Res; 1974; Suppl 4():174-80. PubMed ID: 4423203
    [No Abstract]   [Full Text] [Related]  

  • 32. [Some metabolic indices in coronary arterial disease].
    Bialkowska M; Cybulska B; Szostak WB
    Pol Tyg Lek; 1972 Oct; 27(40):1550-3. PubMed ID: 5081824
    [No Abstract]   [Full Text] [Related]  

  • 33. [The prevalence of hyperlipoproteidemia and hyperglicemia in males covered by the Polish trial on prevention of ischaemic heart disease (author's transl)].
    Chotkowska E; Szostak WB; Rywik S; Wasowicz B; Magdoń M; Celiński A
    Przegl Lek; 1979; 36(10):743-8. PubMed ID: 515459
    [No Abstract]   [Full Text] [Related]  

  • 34. [Incidence of chronic nonspecific diseases of the respiratory system in male population covered by programme for prevention of coronary heart disease (author's transl)].
    Gałuszka Z; Pach J; Magdon M; Glinka W; Kulig E; Kulig J
    Przegl Lek; 1976; 33(6):639-43. PubMed ID: 959618
    [No Abstract]   [Full Text] [Related]  

  • 35. [Physical activity at work and other factors of coronary heart disease risk (author's transl)].
    Sznajd J; Adamek-Guzik ; Nowacki G; Wasowicz B; Hartwich A; Kulig J
    Przegl Lek; 1975; 32(6):559-62. PubMed ID: 1144827
    [No Abstract]   [Full Text] [Related]  

  • 36. [The lipoproteic state in patients with coronary heart disease (author's transl)].
    Catalano M; Carzaniga G; Garimoldi M; Sala R; Castelfranco M; Libretti A
    G Ital Cardiol; 1981; 11(12):1944-7. PubMed ID: 7346295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischaemic heart disease in diabetes mellitus.
    Shah LJ; Mukerjee DK; Damany SJ
    J Assoc Physicians India; 1970 Dec; 18(12):983-7. PubMed ID: 5509036
    [No Abstract]   [Full Text] [Related]  

  • 38. [Physical fitness among the industrial population of middle-aged men with risk factors of ischaemic heart disease (author's transl)].
    Simon J; Techlová R; Procházka M; Pribil M; Cajzl L; Trávnícek M; Snebergerová R; Krajzinherová A
    Cas Lek Cesk; 1981 Nov; 120(46):1398-1401. PubMed ID: 7317923
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood glucose and coronary artery disease in nondiabetic patients.
    Nielson C; Lange T; Hadjokas N
    Diabetes Care; 2006 May; 29(5):998-1001. PubMed ID: 16644627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Some problems before analyzing blood glucose (author's transl)].
    Wakabayashi M
    Rinsho Byori; 1974 Nov; 22(11):761-5. PubMed ID: 4477220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.